The identification of clinical candidat... [Bioorg Med Chem Lett. 2003] - PubMed

Save items

loading

Related citations in PubMed

The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2. [Bioorg Med Chem Lett. 2001]
The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2.
Boyd HF, Hammond B, Hickey DM, Ife RJ, Leach CA, Lewis VA, Macphee CH, Milliner KJ, Pinto IL, Smith SA, et al. Bioorg Med Chem Lett. 2001 Mar 12; 11(5):701-4.
The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in man. [Bioorg Med Chem Lett. 2002]
The discovery of SB-435495. A potent, orally active inhibitor of lipoprotein-associated phospholipase A(2) for evaluation in man.
Blackie JA, Bloomer JC, Brown MJ, Cheng HY, Elliott RL, Hammond B, Hickey DM, Ife RJ, Leach CA, Lewis VA, et al. Bioorg Med Chem Lett. 2002 Sep 16; 12(18):2603-6.
1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A(2). [Bioorg Med Chem Lett. 2001]
1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A(2).
Bloomer JC, Boyd HF, Hickey DM, Ife RJ, Leach CA, Macphee CH, Milliner KJ, Pinto IL, Rawlings DA, Smith SA, et al. Bioorg Med Chem Lett. 2001 Jul 23; 11(14):1925-9.
Review SB-480848. GlaxoSmithKline. [Curr Opin Investig Drugs. 2004]
Review SB-480848. GlaxoSmithKline.
Rotella DP. Curr Opin Investig Drugs. 2004 Mar; 5(3):348-51.
Review Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target. [Curr Opin Pharmacol. 2006]
Review Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target.
Macphee CH, Nelson J, Zalewski A. Curr Opin Pharmacol. 2006 Apr; 6(2):154-61. Epub 2006 Feb 21.

See reviews... See all...

Cited by 6 PubMed Central articles

Review Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. [Chem Rev. 2011]
Review Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention.
Dennis EA, Cao J, Hsu YH, Magrioti V, Kokotos G. Chem Rev. 2011 Oct 12; 111(10):6130-85. Epub 2011 Sep 12.
Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke. [Cerebrovasc Dis. 2009]
Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke.
Elkind MS, Tai W, Coates K, Paik MC, Sacco RL. Cerebrovasc Dis. 2009; 27(1):42-50. Epub 2008 Nov 15.
Review Phospholipase A2 structure/function, mechanism, and signaling. [J Lipid Res. 2009]
Review Phospholipase A2 structure/function, mechanism, and signaling.
Burke JE, Dennis EA. J Lipid Res. 2009 Apr; 50 Suppl:S237-42. Epub 2008 Nov 14.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
BioAssay
PubChem BioAssay experiments on the biological activities of small molecules that cite the current articles. The depositors of BioAssay data provide these references.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

The identification of clinical candidate SB-480848: a potent inhibitor of lipopr...
The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2.
Bioorg Med Chem Lett. 2003 Mar 24 ;13(6):1067-70.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Chemical Information

Supplemental Content

Save items

Related citations in PubMed

Cited by 6 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information